Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Domagrozumab Phase 2 Study in Male Participants (Japan)
jRCT2080223525Phase 2Terminated
- Start
- May 2017
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 2 trial of domagrozumab (2 arms). Started May 2017; status: terminated.
02
Drugs
domagrozumab
Beyond the preview
Go deeper on jRCT2080223525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223525.